Substituted isoxazoles as potent inhibitors of p38 MAP kinase

被引：31

作者：

Laufer, Stefan A.

Margutti, Simona

Fritz, Martina D.

机构：

[1] Institute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Eberhard Karls University of Tübingen, 72076 Tübingen

来源：

CHEMMEDCHEM | 2006年 / 1卷 / 02期

关键词：

Cytochromes; Enzymes; Inhibitors; Isoxazoles; p38 MAP kinase;

D O I：

10.1002/cmdc.200500025

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In a continuous effort to develop improved p38 MAP (mitogen-activated protein) kinase inhibitors, we focused our attention on the suitability of the isoxozole ring as a bioisosteric replacement for the imidazole ring of SB-203580. 3,4- and 4,5-disubstituted as well as 3,4,5-trisubstituted isoxazole derivatives were synthesized. These compounds were tested in an in vitro enzyme-linked immunosorbent assay of isolated p38 MAP kinase and for inhibitory potency against cytochrome P450. Compound 4a displays a highly promising profile for development as an anti-inflammatory agent owing to its enhanced suppression of cytokine release, decreased affinity for cytochrome P450 and a twofold decrease in IC50 toward isolated p38 MAP kinase.

引用

页码：197 / 207

页数：11

共 56 条

[11] Rheumatoid arthritis [J].

Feldmann, M ;

Brennan, FM ;

Maini, RN .

CELL, 1996, 85 (03) :307-310

[12] Role of cytokines in rheumatoid arthritis [J].

Feldmann, M ;

Brennan, FM ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440

[13] Pathogenesis of arthritis: recent research progress [J].

Feldmann, M .

NATURE IMMUNOLOGY, 2001, 2 (09) :771-773

[14] Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity [J].

Fitzgerald, CE ;

Patel, SB ;

Becker, JW ;

Cameron, PM ;

Zaller, D ;

Pikounis, VB ;

O'Keefe, SJ ;

Scapin, G .

NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) :764-769

[15] Regulation of stress-induced cytokine production by pyridinylimidazoles; Inhibition of CSBP kinase [J].

Gallagher, TF ;

Seibel, GL ;

Kassis, S ;

Laydon, JT ;

Blumenthal, MJ ;

Lee, JC ;

Lee, D ;

Boehm, JC ;

FierThompson, SM ;

Abt, JW ;

Soreson, ME ;

Smietana, JM ;

Hall, RF ;

Garigipati, RS ;

Bender, PE ;

Erhard, KF ;

Krog, AJ ;

Hofmann, GA ;

Sheldrake, PL ;

McDonnell, PC ;

Kumar, S ;

Young, PR ;

Adams, JL .

BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (01) :49-64

[16] 2,4,5-TRIARYLIMIDAZOLE INHIBITORS OF IL-1 BIOSYNTHESIS [J].

GALLAGHER, TF ;

FIERTHOMPSON, SM ;

GARIGIPATI, RS ;

SORENSON, ME ;

SMIETANA, JM ;

LEE, D ;

BENDER, PE ;

LEE, JC ;

LAYDON, JT ;

GRISWOLD, DE ;

CHABOTFLETCHER, MC ;

BRETON, JJ ;

ADAMS, JL .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (11) :1171-1176

[17]

*GENT CORP, 1998, GENT CORP TECHN B

[18] Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket [J].

Gum, RJ ;

McLaughlin, MM ;

Kumar, S ;

Wang, ZL ;

Bower, MJ ;

Lee, JC ;

Adams, JL ;

Livi, GP ;

Goldsmith, EJ ;

Young, PR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15605-15610

[19]

KAWAI Y, 1994, Patent No. 9419350

[20] p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases [J].

Kumar, S ;

Boehm, J ;

Lee, JC .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) :717-726

← 1 2 3 4 5 6 →